Details

Autor(en) / Beteiligte

• Ilori, Elsie A
• Furuse, Yuki
• Ipadeola, Oladipupo B
• Dan-Nwafor, Chioma C
• Abubakar, Anwar
• Womi-Eteng, Oboma E
• Ogbaini-Emovon, Ephraim
• Okogbenin, Sylvanus
• Unigwe, Uche
• Ogah, Emeka
• Ayodeji, Olufemi
• Abejegah, Chukwuyem
• Liasu, Ahmed A
• Musa, Emmanuel O
• Woldetsadik, Solomon F
• Lasuba, Clement L P
• Alemu, Wondimagegnehu
• Ihekweazu, Chikwe

Titel

Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018

Ist Teil von

• Emerging infectious diseases, 2019-06, Vol.25 (6), p.1066-1074

Ort / Verlag

United States: U.S. National Center for Infectious Diseases

Erscheinungsjahr

2019

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Lassa fever (LF) is endemic to Nigeria, where the disease causes substantial rates of illness and death. In this article, we report an analysis of the epidemiologic and clinical aspects of the LF outbreak that occurred in Nigeria during January 1-May 6, 2018. A total of 1,893 cases were reported; 423 were laboratory-confirmed cases, among which 106 deaths were recorded (case-fatality rate 25.1%). Among all confirmed cases, 37 occurred in healthcare workers. The secondary attack rate among 5,001 contacts was 0.56%. Most (80.6%) confirmed cases were reported from 3 states (Edo, Ondo, and Ebonyi). Fatal outcomes were significantly associated with being elderly; no administration of ribavirin; and the presence of a cough, hemorrhaging, and unconsciousness. The findings in this study should lead to further LF research and provide guidance to those preparing to respond to future outbreaks.